Page 1105 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

27. Turner G, Morrison H, Jones M, et al. An immunohisto- 46. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid
chemical study of the pathology of fatal malaria. Evidence for bolus in African children with severe infection. N Engl J Med.
widespread endothelial activation and a potential role for May 26, 2011;364(26):2483-2495.
ICAM-1 in cerebral sequestration. Am J Pathol. 1994;145(5): 47. Bell D, Peeling RW. Evaluation of rapid diagnostic tests: malaria.
1057-69. Nat Rev Microbiol. September 2006;4(9 suppl):S34-S38.
28. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies 48. Price RN, Uhlemann AC, Brockman A, et al. Mefloquine resis-
of cerebral malaria by postmortem parasite counts. Nat Med. tance in Plasmodium falciparum and increased pfmdr1 gene
February 2004;10(2):143-145. copy number. Lancet. July 31, 2004;364(9432):438-447.
29. Warrell DA, White NJ, Veall N, et al. Cerebral anaerobic glycol- 49. Nickerson JP, Tong KA, Raghavan R. Imaging cerebral malaria
ysis and reduced cerebral oxygen transport in human cerebral with a susceptibility—weighted MR sequence. AJNR Am J
malaria. Lancet. 1988;i:534-538. Neuroradiol. June 2009;30(6):e85-e86.
30. Davis TME, Suputtamongkol Y, Spencer JL, et al. Measures 50. Bruneel F, Tubach F, Corne P, et al. Severe imported falciparum
of capillary permeability in acute falciparum malaria: rela- malaria: a cohort study in 400 critically ill adults. PLoS One.
tion to severity of infection and treatment. Clin Infect Dis. 2010;5(10):e13236.
1992;15:256-266.
51. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate
31. Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: versus quinine in the treatment of severe falciparum malaria
mechanisms of brain injury and strategies for improved neuro- in African children (AQUAMAT): an open-label, randomised
cognitive outcome. Pediatr Res. October 2010;68(4):267-274. trial. Lancet. November 13, 2010;376(9753):1647-1657.
32. Planche T, Krishna S. Severe malaria: metabolic complications. 52. Dondorp A, Nosten F, Stepniewska K, Day N, White N.
Curr Mol Med. March 2006;6(2):141-153. Artesunate versus quinine for treatment of severe falciparum
33. Sasi P, Burns SP, Waruiru C, et al. Metabolic acidosis and other malaria: a randomised trial. Lancet. August 27-September 2,
determinants of hemoglobin-oxygen dissociation in severe 2005;366(9487):717-725.
childhood Plasmodium falciparum malaria. Am J Trop Med 53. White NJ. Antimalarial drug resistance. J Clin Invest. April
Hyg. August 2007;77(2):256-260. 2004;113(8):1084-1092.
34. White NJ, Warrell DA, Chantavanich P, et al. Severe hypogly- 54. Woodrow CJ, Haynes RK, Krishna S. Artemisinins. Postgrad
caemia and hyperinsulinaemia in falciparum malaria. N Engl J Med J. February 2005;81(952):71-78.
Med. 1983;309:61-66.
55. Price R, van Vugt M, Phaipun L, et al. Adverse effects in patients
35. Krishna S, Waller D, ter Kuile F, et al. Lactic acidosis and with acute falciparum malaria treated with artemisinin deriva-
hypoglycaemia in children with severe malaria: pathophysi- tives. Am J Trop Med Hyg. April 1999;60(4):547-555.
ological and prognostic significance. Trans R Soc Trop Med Hyg.
1994;88:67-73. 56. Bethell D, Se Y, Lon C, et al. Dose-dependent risk of neutropenia
after 7-day courses of artesunate monotherapy in Cambodian
36. Day NP, Phu NH, Mai NT, et al. The pathophysiologic and prog- patients with acute Plasmodium falciparum malaria. Clin Infect
nostic significance of acidosis in severe adult malaria. Crit Care Dis. December 15, 2010;51(12):e105-e114.
Med. June 2000;28(6):1833-1840.
57. Maude RJ, Plewes K, Faiz MA, et al. Does artesunate prolong the
37. Waller D, Krishna S, Crawley J, et al. The outcome and electrocardiograph QT interval in patients with severe malaria?
course of severe malaria in Gambian children. Clin Infect Dis. Am J Trop Med Hyg. January 2009;80(1):126-132.
1995;21:577-587.
58. Nealon C, Dzeing A, Muller-Romer U, et al. Intramuscular
38. Marsh K, Forster D, Waruiru C, et al. Indicators of life- bioavailability and clinical efficacy of artesunate in gabonese
threatening malaria in African children. N Engl J Med. children with severe malaria. Antimicrob Agents Chemother.
1995;332:1399-1404. December 2002;46(12):3933-3939.
39. Day N, Phu NH, Bethall D, Hien TT, White NJ. Effects of 59. Phu NH, Tuan PQ, Day N, et al. Randomized controlled trial
dopamine and adrenaline infusions in severe infection. Lancet of artesunate or artemether in Vietnamese adults with severe
(letter). 1996;348:1099-1100. falciparum malaria. Malar J. 2010;9:97.
40. Krishna S, Taylor AM, Supanaranond W, et al. Thiamine 60. WHO. Guidelines for the treatment of malaria. 2010. http://
deficiency and malaria in adults from southeast Asia. Lancet. www.who.int/malaria/publications/atoz/9789241547925/en/
1999;353:546-549. index.html. Accessed June 16, 2011.
41. Blumberg L, Lee RP, Lipman J, Beards S. Predictors of mortality 61. Artemether-Quinine Meta-analysis Study Group. A meta-
in severe malaria: a two year experience in a non-endemic area. analysis using individual patient data of trials comparing
Anaesth Intensive Care. April 1996;24(2):217-223. artemether with quinine in the treatment of severe falciparum
42. Phu NH, Hien TT, Mai NT, et al. Hemofiltration and peritoneal malaria. Trans R Soc Trop Med Hyg. November-December
dialysis in infection-associated acute renal failure in Vietnam. 2001;95(6):637-650.
N Engl J Med. September 19, 2002;347(12):895-902. 62. White NJ, Looareesuwan S, Warrell DA, et al. Quinine loading
43. Abdalla S, Pasvol G, eds. Malaria. A Hematological Perspective. dose in cerebral malaria. Am J Trop Med Hyg. 1983;32:1-5.
London: Imperial College Press; 2004. 63. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine
44. Planche T. Malaria and fluids—balancing acts. Trends Parasitol. and amodiaquine. Clinical implications. Clin Pharmacokinet.
December 2005;21(12):562-567. 1996;30:263-299.
45. Planche T, Onanga M, Schwenk A, et al. Assessment of vol- 64. Krishna S, Nagaraja NV, Planche T, et al. Population pharmacoki-
ume depletion in children with malaria. PLoS Med. October netics of intramuscular quinine in children with severe malaria.
2004;1(1):e18. Antimicrob Agents Chemother. June 2001;45(6):1803-1809.

Section05-O-ref.indd 2 1/20/2015 4:51:25 PM